22nd Century Group Rings the Closing Bell

About This Event

22nd Century Group (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, visits the Nasdaq MarketSite in Times Square in celebration of the launch of VLN^®. VLN^® is the only 95% reduced nicotine combustible cigarette designated as a Modified Risk Tobacco Product (MRTP) by the U.S. Food and Drug Administration (FDA). FDA’s MRTP designation enables VLN^® to carry the headline claim of “helps you smoke less”, describing the benefits of a reduced nicotine cigarette for adult smokers looking to change their relationship with nicotine.

In honor of the occasion, John J. Miller, President of Tobacco Business, and James A. Mish, Chief Executive Officer, ring the Closing Bell.